Indian Journal Watch: 31 October 2026

Indian Journal Watch, InfectionIndia.com

Indian Journal Watch

31 October 2026

Peer-reviewed microbiology, infectious disease, AMR and infection-control papers from India and South Asia, published or added to PubMed from 29 to 31 October 2026.

Lead articles

IPC & healthcare-associated infection · Critical Care

Chlorhexidine within a standardized oral-care bundle for the prevention of ventilator-associated pneumonia: a pragmatic cluster-randomized crossover trial in six medical intensive care units

Critical Care · doi:10.1186/s13054-026-06217-0 · PubMed 42958418

What
A pragmatic cluster-randomised crossover trial from IMS and SUM Hospital, Bhubaneswar, testing whether adding 0.12% chlorhexidine (CHX) to a standardised oral-care bundle gives incremental benefit in preventing ventilator-associated pneumonia (VAP) in medical intensive care units.
Design
Prospective AB/BA crossover trial in six adult medical ICUs of a single tertiary-care academic hospital. ICUs were randomised to the multicomponent oral-care bundle with or without 0.12% CHX for 9-month periods, with a 1-month wash-in and re-training interval. Consecutive adults ventilated for ≥ 48 h were included. The primary outcome was VAP incidence density (CPIS > 6) per 1,000 ventilator-days (Poisson GEE analysis). Registered as CTRI/2024/02/062201.
Key findings
A total of 1,035 patients (637 No CHX, 398 CHX) accrued 10,024 ventilator-days. VAP occurred in 100/5,918 ventilator-days (16.9 per 1,000) without CHX vs. 77/4,106 (18.8 per 1,000) with CHX; the adjusted incidence rate ratio was 1.08 (95% CI 0.84-1.38; p = 0.56). 28-day mortality was 28.7% vs. 26.4% (adjusted OR 0.87, 95% CI 0.65-1.15; p = 0.33). ICU length of stay was longer in the CHX arm (adjusted mean difference + 0.89 days, 95% CI + 0.19 to + 1.58; p = 0.013). BOAS and CPOT scores did not differ.
Limitations
Single-hospital study with unequal arm sizes; VAP was defined by a clinical score (CPIS > 6).
Relevance to India
The trial adds Indian ICU data to the debate on routine chlorhexidine oral care. The authors conclude that routine CHX use provided no clear incremental benefit in a mixed medical ICU population.

Antimicrobial resistance · Diagnostics · Journal of Clinical Microbiology

Performance of mCIM/eCIM in Enterobacterales strains co-encoding NDM and OXA-48-like carbapenemases from South India

Journal of Clinical Microbiology · doi:10.1128/jcm.01063-26 · PubMed 42961035

What
A study from Washington University School of Medicine, St Louis, with the Amrita Institute of Medical Sciences, Kochi, assessing how the modified carbapenem inactivation method (mCIM) and EDTA-modified CIM (eCIM) perform in carbapenem-resistant Enterobacterales (CRE) encoding NDM, OXA-48-like, or both carbapenemases.
Design
172 genotypically confirmed carbapenemase-encoding CRE isolates from perirectal swabs of patients admitted to two intensive care units at a hospital in South India were tested by mCIM/eCIM, and results were compared with molecular carbapenemase gene detection. Isolates were Escherichia coli (53.5%), Klebsiella pneumoniae (41.3%) and Enterobacter species (5.3%).
Key findings
112 isolates (65.1%) encoded NDM alone, 23 (13.4%) OXA-48-like alone and 37 (21.5%) both. mCIM positivity was 98.2% for NDM, 47.8% for OXA-48-like and 94.6% for NDM+OXA-48-like encoders; among mCIM-positive isolates, eCIM positivity rates were 99.1%, 91% and 97.1%, respectively. mCIM/eCIM was highly sensitive for classifying NDM encoders as metallo-β-lactamase (MBL) producers but significantly misclassified OXA-48-like encoders as having an MBL or lacking a carbapenemase. Co-encoding isolates were typically reported as MBL producers.
Limitations
Isolates were colonising strains from two ICUs in one hospital; the authors note that the mechanisms underlying the variable assay activity remain to be understood.
Relevance to India
The authors describe this as the largest collection of NDM and OXA-48-like co-encoding Enterobacterales reported to date, and suggest that mCIM/eCIM performance may vary geographically due to variable activity, distribution and combinations of carbapenemases.

More from the journals

Antimicrobial resistance & stewardship

Tuberculosis

Vector-borne & zoonoses

Virology & vaccines

Mycology

Diagnostics

Other

Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *